<- Go Home
IDT Australia Limited
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States. and internationally. It offers microbiological and analytical testing, clinical packaging, and pharmacy services. The company also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, it offers mRNA and ADCs. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
Market Cap
$43.0M
Volume
303.7K
Cash and Equivalents
$504.0K
EBITDA
-$5.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$7.5M
Profit Margin
53.46%
52 Week High
$0.14
52 Week Low
$0.08
Dividend
N/A
Price / Book Value
1.50
Price / Earnings
-6.43
Price / Tangible Book Value
1.50
Enterprise Value
$46.5M
Enterprise Value / EBITDA
-9.07
Operating Income
-$6.1M
Return on Equity
22.75%
Return on Assets
-12.69
Cash and Short Term Investments
$904.0K
Debt
$4.5M
Equity
$23.4M
Revenue
$14.0M
Unlevered FCF
-$7.8M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium